arginine has been researched along with Communicable Diseases, Emerging in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ariey, F; Campagne, P; Criscuolo, A; Fidock, DA; Legrand, E; Mazarati, JB; Mbituyumuremyi, A; Menard, D; Munguti, K; Munyaneza, T; Murindahabi, M; Ndikumana, JM; Ngamije, D; Ringwald, P; Stokes, BH; Umulisa, N; Uwimana, A; Warsame, M | 1 |
Hara, M; Higuchi, W; Iwao, Y; Shibuya, Y; Takano, T; Yamamoto, T | 1 |
2 other study(ies) available for arginine and Communicable Diseases, Emerging
Article | Year |
---|---|
Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.
Topics: Amino Acid Substitution; Animals; Antimalarials; Arginine; Artemisinins; Clonal Evolution; Communicable Diseases, Emerging; Drug Resistance; Genotype; Histidine; Humans; In Vitro Techniques; Kelch Repeat; Malaria, Falciparum; Mutation, Missense; Parasitic Sensitivity Tests; Phylogeny; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Rwanda | 2020 |
Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan.
Topics: Abscess; Anti-Bacterial Agents; Arginine; Bacterial Toxins; Communicable Diseases, Emerging; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Exotoxins; Female; Humans; Infant; Interspersed Repetitive Sequences; Japan; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Molecular Epidemiology; Staphylococcal Infections; Subcutaneous Tissue | 2008 |